PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
9 hedge funds and large institutions have $9.94M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
10% less funds holding
Funds holding: 10 → 9 (-1)
14% less capital invested
Capital invested by funds: $11.6M → $9.94M (-$1.67M)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$9.23M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$198K |
| 3 |
Jane Street
New York
|
+$154K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$57K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$3.61M |
| 2 |
CC
Cannell & Co
New York
|
-$150K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.4K |
| 4 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$12K |
| 5 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $6.43M | +$9.23M | +273,757 | New |
|
|
BI
2
BVF Inc
San Francisco,
California
| $3.1M | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $173K | +$198K | +5,876 | +403% |
|
|
4
Jane Street
New York
| $110K | +$154K | +4,564 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $49K | -$16.4K | -486 | -19% |
|
|
CS
6
Credit Suisse
Zurich,
Switzerland
| $40K | +$57K | +1,690 | New |
|
|
7
Group One Trading
Chicago,
Illinois
| $25K | +$29.1K | +862 | +431% |
|
8
UBS Group
Zurich,
Switzerland
| $8K | +$12.1K | +358 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | +$67 | +2 | +7% |
|
|
NMC
10
NEA Management Company
Timonium,
Maryland
| – | -$3.61M | -62,500 | Closed |
|
|
CC
11
Cannell & Co
New York
| – | -$150K | -2,600 | Closed |
|
|
ACM
12
ACT Capital Management
Wayne,
Pennsylvania
| – | -$12K | -200 | Closed |
|
|
HI
13
Harbour Investments
Madison,
Wisconsin
| – | -$6K | -100 | Closed |
|
14
Morgan Stanley
New York
| – | -$2K | -30 | Closed |
|
PHXM Hedge Fund Activity: Q4 2021 in Review
9 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q4 2021, worth a combined $9.94M — down 14% from $11.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PHXM and 4 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $9.23M. The largest seller was NEA Management Company, exiting entirely with an estimated $3.61M sold.
- 9 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q4 2021, down from 10 in Q3 2021.
- Funds reported $9.94M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q4 2021, down 14% quarter-over-quarter.
- 4 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q4 2021 and 5 closed out, a net change of -1 holder.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares buyer in Q4 2021 was Armistice Capital, an estimated $9.23M added.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q4 2021 was NEA Management Company, an estimated $3.61M sold.
Based on aggregated 13F filings for Q4 2021.